Spotlight -

B + L Dry Eye Series|

Transforming Glaucoma Management|

Zeiss Clinical Cases

Viewing

|Videos|September 10, 2021

Comparison of suitable naïve versus pretreated DMO patients

Author(s)OTE Staff Reports

Dr Javier Zarranz-Ventura discusses the key highlights from his presentation on a clinical investigation of suitable naïve versus pretreated DMO patients, and what it means for future research.

Dr Javier Zarranz-Ventura, a vitreoretinal consultant at
Institut Clínic de Oftalmologia (ICOF), Hospital Clínic de Barcelona andInstitut de Investigacions Biomediques August Pi i Sunyer (IDIBAPS), discusses the key highlights from his presentation on a clinical investigation of suitable naïve versus pretreated DMO patients, and what it means for future research.

See more EURETINA coverage

Newsletter

Don’t miss out—get OT Europe updates delivered straight to your inbox.

Related Content

(Ophthalmology Times Europe) Lab bench to bedside to backpack: AI’s reach in retinal disease

AI's reach in retinal disease: Lab bench to bedside to backpack

BySheryl Stevenson

September 7th 2026

Effect of a maternal high-fat diet on the peripheral retina in mice | Gintare Urbonaite, PhD | © Gintare Urbonaite, PhD

Effect of a maternal high-fat diet on the peripheral retina in mice

ByLynda Charters

August 12th 2026

(Image credit: Ophthalmology Times Europe) Functional OCT takes retinal imaging where structure alone cannot go

Functional OCT takes retinal imaging where structure alone cannot go

ByAnat Loewenstein, MD, MHA,Sheryl Stevenson

July 25th 2026

Mikhail Boukhny and Andy Chang | Ophthalmology Times Europe

Hands-on training, real surgeon input: inside BVI's new Experience Hub

ByMikhail Boukhny,Andy Chang,Lucia Gambuzza

July 3rd 2026

Prof. Dr. Ömür Uçakhan Gündüz | Ophthalmology Times Europe

EuDEC 2026: ectoine eye drops show meaningful symptom and tear film improvements in dry eye disease

ByProf. Dr. Ömür Uçakhan Gündüz,Lucia Gambuzza

June 30th 2026

Latest CME

Precision Vision: Integrating Mechanistic Insight and Clinical Strategy in ADC-Associated Ocular Toxicity

Precision Vision: Integrating Mechanistic Insight and Clinical Strategy in ADC-Associated Ocular Toxicity

Neel Pasricha, MD; Asim V. Farooq, MD; Susana Campos, MD, MPH

Treatment Optimization in the Evolving Anti-VEGF Era

Treatment Optimization in the Evolving Anti-VEGF Era

Carl Danzig, MD, FASRS; Sruthi Arepalli, MD; Priya Vakharia, MD, FASRS

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - NYC Metro

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - NYC Metro

Deep Parikh, MD

(CME Track) Embracing the Interventional Glaucoma Mindset: A Paradigm Shift in Contemporary Glaucoma Management

(CME Track) Embracing the Interventional Glaucoma Mindset: A Paradigm Shift in Contemporary Glaucoma Management

Mary Qiu, MD; Paul Singh, MD; Danica J. Marrelli, OD, FAAO

(COPE Track) Emerging Therapeutic Advancements in Dry Eye Disease Management

(COPE Track) Emerging Therapeutic Advancements in Dry Eye Disease Management

Rahul Tonk, MD; Jade Coats, OD, FAAO; Aaleya Koreishi, MD; Zeba Syed, MD

Trending on Eye Care Network - Ophthalmology Times

Comments from the FDA Advisory Committee meeting on SYD-101

OCT-980 receives FDA orphan drug designation for retinitis pigmentosa

FAQ: Diabetic eye disease awareness month 2026

First patient dosed in phase 3 NPI-001 trial for Usher syndrome RP

Mediterranean diet linked to slower AMD progression across stages